Tissara 90mg Tablet

Tissara 90mg Tablet contains Ticagrelor as its active ingredient. Ticagrelor belongs to a class of medications known as antiplatelet drugs. It is prescribed to prevent blood clots in patients with acute coronary syndromes (ACS), such as unstable angina or myocardial infarction (heart attack), by inhibiting platelet aggregation and reducing the risk of cardiovascular events.

Uses:

Tissara 90mg Tablet is primarily used for the prevention of thrombotic events in patients with ACS, including those undergoing percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). Ticagrelor works by blocking the adenosine diphosphate (ADP) receptor on platelets, thereby inhibiting platelet activation and aggregation, and reducing the risk of myocardial infarction, stroke, or cardiovascular death.

Dosage:

The dosage of Tissara 90mg Tablet is determined based on the patient’s medical condition, risk factors, and concomitant medications. It is usually taken orally, with or without food, as directed by the healthcare provider. Patients should follow the prescribed dosage regimen and adhere to regular monitoring to ensure optimal antiplatelet therapy.

Side Effects:

Common side effects associated with Tissara 90mg Tablet may include bleeding, dyspnea (shortness of breath), headache, dizziness, and nausea. These side effects are usually mild to moderate and transient, but patients should seek medical attention if they experience severe bleeding, chest pain, or signs of an allergic reaction such as rash, itching, or swelling.

Precautions:

Before using Tissara 90mg Tablet, patients should inform their healthcare provider about any pre-existing medical conditions, allergies, or medications they are currently taking. It is essential to use caution in patients with a history of bleeding disorders, stroke, or transient ischemic attack (TIA), as well as those taking other antiplatelet or anticoagulant medications. Ticagrelor may interact with certain medications, so it’s crucial to review the patient’s medication regimen to prevent potential interactions.

When Not to Use:

Tissara 90mg Tablet is contraindicated in patients with a known hypersensitivity to Ticagrelor or any other components of the medication. It should not be used in patients with active pathological bleeding, such as peptic ulcer disease or intracranial hemorrhage. Additionally, this medication is not recommended for use in patients with severe liver or kidney impairment.